Investigational Site Number :032091

Capital Federal, Buenos Aires C1426ABP

0 studies enrolling now · 1 studies all time

What they study most

Asthma

Studies at this site

• Continuation of TRAVERSE- LTS12551 Evaluating Dupilumab Safety in Patients With Asthma (Long-Term Follow-Up) — Completed